The Cost-Effectiveness Evaluation of Canagliflozin Versus Dapagliflozin In Patients with type 2 Diabetes Mellitus Inadequately Controlled On Metformin Monotherapy In Spain
May 1, 2015, 00:00
10.1016/j.jval.2015.03.357
https://www.valueinhealthjournal.com/article/S1098-3015(15)00414-3/fulltext
Title :
The Cost-Effectiveness Evaluation of Canagliflozin Versus Dapagliflozin In Patients with type 2 Diabetes Mellitus Inadequately Controlled On Metformin Monotherapy In Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00414-3&doi=10.1016/j.jval.2015.03.357
First page :
A61
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
1460